A citation-based method for searching scientific literature

Emma D Deeks. Drugs 2019
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Marc Evans, Debbie Hicks, Dipesh Patel, Vinod Patel, Phil McEwan, Umesh Dashora. Diabetes Ther 2020
6
33

Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017.
Joseph E O'Reilly, Luke A K Blackbourn, Thomas M Caparrotta, Anita Jeyam, Brian Kennon, Graham P Leese, Robert S Lindsay, Rory J McCrimmon, Stuart J McGurnaghan, Paul M McKeigue,[...]. Diabetologia 2020
1
100

The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis.
Kevin Bryan Lo, Fahad Gul, Pradhum Ram, Aaron Y Kluger, Kristen M Tecson, Peter A McCullough, Janani Rangaswami. Cardiorenal Med 2020
15
33

Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials.
Per-Henrik Groop, Paresh Dandona, Moshe Phillip, Pieter Gillard, Steven Edelman, Johan Jendle, John Xu, Markus F Scheerer, Fredrik Thoren, Nayyar Iqbal,[...]. Lancet Diabetes Endocrinol 2020
1
100

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
973
33

Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2.
Chantal Mathieu, Paresh Dandona, Andreas L Birkenfeld, Troels Krarup Hansen, Nayyar Iqbal, John Xu, Enrico Repetto, Markus Florian Scheerer, Fredrik Thoren, Moshe Phillip. Diabetes Obes Metab 2020
3
33

SGLT2 inhibitors in type 1 diabetes: knocked down, but up again?
John R Petrie. Lancet Diabetes Endocrinol 2017
7
33

Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010.
Shona J Livingstone, Daniel Levin, Helen C Looker, Robert S Lindsay, Sarah H Wild, Nicola Joss, Graham Leese, Peter Leslie, Rory J McCrimmon, Wendy Metcalfe,[...]. JAMA 2015
222
33

Endoplasmic Reticulum Stress: A Critical Molecular Driver of Endothelial Dysfunction and Cardiovascular Disturbances Associated with Diabetes.
Hatem Maamoun, Shahenda S Abdelsalam, Asad Zeidan, Hesham M Korashy, Abdelali Agouni. Int J Mol Sci 2019
27
33

The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases.
Wioletta Rozpędek-Kamińska, Natalia Siwecka, Adam Wawrzynkiewicz, Radosław Wojtczak, Dariusz Pytel, J Alan Diehl, Ireneusz Majsterek. Int J Mol Sci 2020
5
33

Vitamin D level and gene polymorphisms in Korean children with type 1 diabetes.
Hyo-Kyoung Nam, Young-Jun Rhie, Kee-Hyoung Lee. Pediatr Diabetes 2019
7
33

Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes.
Min Joo Kim, Mi Na Kim, Se Hee Min, Dong-Sik Ham, Ji-Won Kim, Kun-Ho Yoon, Kyong Soo Park, Hye Seung Jung. Metabolism 2019
5
33

Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival.
H P Harding, H Zeng, Y Zhang, R Jungries, P Chung, H Plesken, D D Sabatini, D Ron. Mol Cell 2001
812
33

Endoplasmic Reticulum Stress Contributes to Nociception via Neuroinflammation in a Murine Bone Cancer Pain Model.
Yanting Mao, Chenchen Wang, Xinyu Tian, Yulin Huang, Ying Zhang, Hao Wu, Shuai Yang, Ke Xu, Yue Liu, Wei Zhang,[...]. Anesthesiology 2020
3
33

Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues.
Estefania Burgos-Morón, Zaida Abad-Jiménez, Aranzazu Martínez de Marañón, Francesca Iannantuoni, Irene Escribano-López, Sandra López-Domènech, Christian Salom, Ana Jover, Vicente Mora, Ildefonso Roldan,[...]. J Clin Med 2019
49
33

PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts.
Giuseppina Amodio, Ornella Moltedo, Dominga Fasano, Lucrezia Zerillo, Marco Oliveti, Paola Di Pietro, Raffaella Faraonio, Paolo Barone, Maria Teresa Pellecchia, Anna De Rosa,[...]. Front Neurosci 2019
11
33

1,25(OH)2D3 Activates Autophagy to Protect against Oxidative Damage of INS-1 Pancreatic Beta Cells.
Dawei He, Yubin Wang, Ruijiang Liu, Aolin He, Shasha Li, Xuejie Fu, Zhengyu Zhou. Biol Pharm Bull 2019
2
50



Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes.
Marco Infante, Camillo Ricordi, Janine Sanchez, Michael J Clare-Salzler, Nathalia Padilla, Virginia Fuenmayor, Carmen Chavez, Ana Alvarez, David Baidal, Rodolfo Alejandro,[...]. Nutrients 2019
24
33

Role of endoplasmic reticulum stress and protein misfolding in disorders of the liver and pancreas.
Jan Lukas, Jola Pospech, Christina Oppermann, Christina Hund, Katharina Iwanov, Supansa Pantoom, Janine Petters, Moritz Frech, Susanne Seemann, Franziska-Gisela Thiel,[...]. Adv Med Sci 2019
16
33

Endoplasmic reticulum stress contributes to NMDA-induced pancreatic β-cell dysfunction in a CHOP-dependent manner.
Xiao-Ting Huang, Wei Liu, Yong Zhou, Mei Sun, Chen-Chen Sun, Chen-Yu Zhang, Si-Yuan Tang. Life Sci 2019
2
50

The unfolded protein response in ischemic heart disease.
Xiaoding Wang, Lin Xu, Thomas G Gillette, Xuejun Jiang, Zhao V Wang. J Mol Cell Cardiol 2018
29
33

Treating vitamin D deficiency in children with type I diabetes could improve their glycaemic control.
Dinesh Giri, Dona Pintus, Girvan Burnside, Atrayee Ghatak, Fulya Mehta, Princy Paul, Senthil Senniappan. BMC Res Notes 2017
13
33

Where is the vitamin D receptor?
Yongji Wang, Jinge Zhu, Hector F DeLuca. Arch Biochem Biophys 2012
246
33

The endoplasmic reticulum: structure, function and response to cellular signaling.
Dianne S Schwarz, Michael D Blower. Cell Mol Life Sci 2016
238
33


Vitamin D Increases Glucose Stimulated Insulin Secretion from Insulin Producing Beta Cells (INS1E).
Mette Eskild Bornstedt, Nina Gjerlaugsen, Milaim Pepaj, May K L Bredahl, Per M Thorsby. Int J Endocrinol Metab 2019
3
33


Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
Dieter Rondas, Inne Crèvecoeur, Wannes D'Hertog, Gabriela Bomfim Ferreira, An Staes, Abhishek D Garg, Decio L Eizirik, Patrizia Agostinis, Kris Gevaert, Lut Overbergh,[...]. Diabetes 2015
85
33

Exposure to environmental chemicals and type 1 diabetes: an update.
Sarah G Howard. J Epidemiol Community Health 2019
11
33

A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.
Nadia Giarratana, Giuseppe Penna, Susana Amuchastegui, Roberto Mariani, Kenn C Daniel, Luciano Adorini. J Immunol 2004
124
33


Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells.
Jun Sung Moon, Udayakumar Karunakaran, Suma Elumalai, In-Kyu Lee, Hyoung Woo Lee, Yong-Woon Kim, Kyu Chang Won. J Diabetes Complications 2017
25
33

Type 1 diabetes associated autoimmunity.
George J Kahaly, Martin P Hansen. Autoimmun Rev 2016
68
33



Protective effects of γ-aminobutyric acid against H2O2-induced oxidative stress in RIN-m5F pancreatic cells.
Xue Tang, Renqiang Yu, Qin Zhou, Shanyu Jiang, Guowei Le. Nutr Metab (Lond) 2018
7
33

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
136
33

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Anne Pernille Ofstad, Egon Pfarr, Waheed Jamal,[...]. Lancet 2020
42
33

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).
John J V McMurray, David L DeMets, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Anna M Langkilde, Felipe A Martinez, Olof Bengtsson, Piotr Ponikowski, Marc S Sabatine,[...]. Eur J Heart Fail 2019
71
33

Do We Need Clinical Events Committees to Adjudicate End Points?
Mark C Petrie, John J V McMurray. Circ Heart Fail 2020
1
100

Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry.
Muthiah Vaduganathan, Stephen J Greene, Shuaiqi Zhang, Maria Grau-Sepulveda, Adam D DeVore, Javed Butler, Paul A Heidenreich, Joanna C Huang, Michelle M Kittleson, Karen E Joynt Maddox,[...]. JAMA Cardiol 2020
3
33

Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad.
Preethika Ekanayake, Christopher Hupfeld, Sunder Mudaliar. Curr Diab Rep 2020
2
50

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
764
33

Diabetic ketoacidosis with SGLT2 inhibitors.
Giovanni Musso, Francesca Saba, Maurizio Cassader, Roberto Gambino. BMJ 2020
3
33

Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial.
Milton Packer, Javed Butler, Gerasimos S Filippatos, Waheed Jamal, Afshin Salsali, Janet Schnee, Karen Kimura, Cordula Zeller, Jyothis George, Martina Brueckmann,[...]. Eur J Heart Fail 2019
31
33

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,[...]. N Engl J Med 2021
16
33

Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF.
Phil McEwan, Oliver Darlington, John J V McMurray, Pardeep S Jhund, Kieran F Docherty, Michael Böhm, Mark C Petrie, Klas Bergenheim, Lei Qin. Eur J Heart Fail 2020
7
33

The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics.
John J V McMurray, David L DeMets, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Anna Maria Langkilde, Felipe A Martinez, Olof Bengtsson, Piotr Ponikowski, Marc S Sabatine,[...]. Eur J Heart Fail 2019
45
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.